InChI
1S/C48H82N16O13.H2O4S/c1-27(2)24-37-47(76)59-32(11-19-52)41(70)56-31(10-18-51)43(72)61-35(14-22-65)39(68)54-21-13-34(45(74)57-33(12-20-53)44(73)64-38(48(77)63-37)25-28-6-4-3-5-7-28)60-42(71)30(9-17-50)58-46(75)36(15-23-66)62-40(69)29(8-16-49)55-26-67;1-5(2,3)4/h3-7,26-27,29-38,65-66H,8-25,49-53H2,1-2H3,(H,54,68)(H,55,67)(H,56,70)(H,57,74)(H,58,75)(H,59,76)(H,60,71)(H,61,72)(H,62,69)(H,63,77)(H,64,73);(H2,1,2,3,4)
InChI key
HNDFYNOVSOOGDU-UHFFFAOYSA-N
form
liquid
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze
color
clear
shipped in
wet ice
storage temp.
−20°C
Quality Level
General description
一种抑制磷脂敏感性 Ca2+ 依赖性蛋白激酶的抗生素。硫酸多粘菌素 B1 和硫酸多粘菌素 B2 的混合物。与细胞壁结合,使其更具渗透性,引起液体吸收。对革兰氏阴性细菌有效。
Biochem/physiol Actions
≥7500单位/mg
Physical form
在H₂O中以50 mg/ml的浓度提供。
Preparation Note
初次融化后,等分并冷冻(-20°C)。
Other Notes
Lucas, M., et al. 1994.Biochem.Pharmacol.47, 667.
Ngezahayo,A. and Kolb, H.A.1993.Pflugers Arch.422, 413.
Kubo,M. and Okada,Y. 1992.J. Physiol.456, 351.
Strasser,R.H.,et al. 1992.Circ.Res.70, 1304.
Hegemann,L., et al. 1991.Eur. J. Pharmacol.207, 17.
Inaba,H. and Finkins,J.P. 1991.Am. J. Physiol.261, R26.
Marra, M.N., et al. 1990.J. Immunol.144, 662.
Ngezahayo,A. and Kolb, H.A.1993.Pflugers Arch.422, 413.
Kubo,M. and Okada,Y. 1992.J. Physiol.456, 351.
Strasser,R.H.,et al. 1992.Circ.Res.70, 1304.
Hegemann,L., et al. 1991.Eur. J. Pharmacol.207, 17.
Inaba,H. and Finkins,J.P. 1991.Am. J. Physiol.261, R26.
Marra, M.N., et al. 1990.J. Immunol.144, 662.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
毒性:有害(C)
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持